Atlas Trials

A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Clinical trial NCT01267084 · COMPLETED

Trial details

NCT number
NCT01267084
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neoplasm Metastases
Start date
2011-02-01
Primary completion
2012-11-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.